CompletedNot Applicable

Identification of Gulf War Illness (GWI) Biomarkers

United States76 participantsStarted 2017-01-18

Plain-language summary

The scientists working on this study want to use blood samples to identify components in blood, such as protein, lipids and their breakdown products to determine if they can be used for diagnosing Gulf War Illness (GWI). An additional goal is to examine the relationship of changes in these markers with the exposures and symptoms associated with GWI. The Scientists will also prepare RNA and DNA from the blood samples for genetic analyses of certain proteins known to increase the risk for GWI. This information will be one of the factors included in the analysis of results from the protein studies.

Who can participate

Age range35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Diagnosed or being treated by a physician for any of the following (Steele et al, 2000) and deemed clinically significant per the discretion of the PI:
✕. Cancer (except for non-melanoma skin cancers)
✕. Chronic infectious disease
✕. Problems resulting from postwar injuries.
✕. Liver disease
✕. Lupus
✕. Multiple sclerosis
✕. Stroke

What they're measuring

Lipid bio markers

Timeframe: 2017 to 2019

Trial details

NCT IDNCT03082638

SponsorRoskamp Institute Inc.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Gulf War Illness trials